GENOMIC LANDSCAPE OF METASTATIC HORMONE- NAIVE PROSTATE CANCER

被引：0
|
作者：
Mizuno, Kei
Akamatsu, Shusuke
Sumiyoshi, Takayuki
Goto, Takayuki
Kobayashi, Takashi
Yamasaki, Toshinari
Inoue, Takahiro
Fujimoto, Akihiro
Ogawa, Osamu
机构：
来源：
JOURNAL OF UROLOGY | 2020年 / 203卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP16-17
引用
收藏
页码：E222 / E222
页数：1
相关论文
共 50 条
  • [21] Enrichment and propagation of circulating tumour cells in men with hormone naive metastatic prostate cancer
    Rhee, Handoo
    Gunter, Jennifer
    Jovanovic, Lidija
    Williams, Elizabeth D.
    Hollier, Brett
    Vela, Ian
    Nelson, Colleen C.
    BJU INTERNATIONAL, 2015, 116 : 33 - 33
  • [22] Prognostic Role of Dynamic Changes in Serological Markers in Metastatic Hormone Naive Prostate Cancer
    Roy, Soumyajit
    Sun, Yilun
    Wallis, Christopher J. D.
    Kishan, Amar U.
    Morgan, Scott C.
    Spratt, Daniel E.
    Malone, Shawn
    Saad, Fred
    CANCERS, 2023, 15 (17)
  • [23] The optimal treatment of metastatic hormone-naive prostate cancer: abiraterone acetate or docetaxel?
    Aoun, Fouad
    El Rassy, Elie
    Sleilaty, Ghassan
    Assi, Tarek
    Bakouny, Ziad
    Kattan, Joseph
    FUTURE ONCOLOGY, 2017, 13 (30) : 2785 - 2790
  • [24] Metastatic Hormone-Sensitive Prostate Cancer A Review of the Current Treatment Landscape
    Kinsey, Emily N.
    Zhang, Tian
    Armstrong, Andrew J.
    CANCER JOURNAL, 2020, 26 (01): : 64 - 75
  • [25] The Rapidly Evolving Treatment Landscape of Metastatic Hormone-Sensitive Prostate Cancer
    Yu, Eun-mi
    Patel, Ishan
    Hwang, Min Woo
    Polani, Faran
    Aragon-Ching, Jeanny B.
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2024, 18
  • [26] Race and prostate cancer: genomic landscape
    Arenas-Gallo, Camilo
    Owiredu, Jude
    Weinstein, Ilon
    Lewicki, Patrick
    Basourakos, Spyridon P.
    Vince, Randy, Jr.
    Al Awamlh, Bashir Al Hussein
    Schumacher, Fredrick R.
    Spratt, Daniel E.
    Barbieri, Christopher E.
    Shoag, Jonathan E.
    NATURE REVIEWS UROLOGY, 2022, 19 (09) : 547 - 561
  • [27] Race and prostate cancer: genomic landscape
    Camilo Arenas-Gallo
    Jude Owiredu
    Ilon Weinstein
    Patrick Lewicki
    Spyridon P. Basourakos
    Randy Vince
    Bashir Al Hussein Al Awamlh
    Fredrick R. Schumacher
    Daniel E. Spratt
    Christopher E. Barbieri
    Jonathan E. Shoag
    Nature Reviews Urology, 2022, 19 : 547 - 561
  • [28] Leading from the front: Real-world treatment of metastatic hormone- sensitive prostate cancer in the Northwest of England
    Singh, A.
    Arif, Z.
    Birtle, A.
    CLINICAL ONCOLOGY, 2025, 38
  • [29] The complete genomic landscape of metastatic prostate cancer pinpoints clinically targetable subgroups.
    van Dessel, Lisanne Francisca
    van Riet, Job
    Smits, Minke
    Van der Heijden, Michiel Simon
    Hamberg, Paul
    Voest, Emile E.
    Zuetenhorst, Johanna M.
    Steeghs, Neeltje
    Witteveen, Petronella
    Martens, John W. M.
    Hendriks, Mathijs P.
    Bergman, Andre M.
    De Wit, Ronald
    Sleijfer, Stefan
    Cuppen, Edwin P. J. G.
    van de Werken, Harmen J. G.
    Mehra, Niven
    Lolkema, Martijn P.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [30] The treatment landscape of metastatic prostate cancer
    Yamada, Yasutaka
    Beltran, Himisha
    CANCER LETTERS, 2021, 519 : 20 - 29
12345